Laird Norton Wetherby Wealth Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-6,476
Closed -$206K 930
2021
Q1
$206K Buy
+6,476
New +$190K 0.02% 735
2016
Q1
Sell
-2,150
Closed -$219K 486
2015
Q4
$219K Sell
2,150
-96
-4% -$10.8K 0.05% 404
2015
Q3
$400K Buy
2,246
+160
+8% +$37.3K 0.1% 239
2015
Q2
$464K Buy
2,086
+37
+2% +$8.2K 0.11% 223
2015
Q1
$407K Buy
2,049
+105
+5% +$18.6K 0.1% 254
2014
Q4
$278K Buy
1,944
+344
+22% +$46.3K 0.07% 325
2014
Q3
$210K Buy
+1,600
New +$191K 0.06% 397

Other funds holding BHC

Laird Norton Wetherby Wealth Management's BHC Position: Q2 2021 in Review

Laird Norton Wetherby Wealth Management sold out of Bausch Health (BHC) in Q2 2021, closing a stake of 6,476 shares — an estimated $206K sold.

Laird Norton Wetherby Wealth Management first reported a position in BHC in Q3 2014 and held it in 7 quarters. The position peaked at $464K in Q2 2015. 357 funds tracked by Wall St. Rank hold BHC as of Q2 2021.

  • Laird Norton Wetherby Wealth Management reported no remaining Bausch Health position as of Q2 2021 after selling out during the quarter.
  • Laird Norton Wetherby Wealth Management sold 6,476 Bausch Health shares in Q2 2021, an estimated $206K.
  • Laird Norton Wetherby Wealth Management first reported a position in Bausch Health in Q3 2014 and held it in 7 quarters.
  • Laird Norton Wetherby Wealth Management's Bausch Health position peaked at $464K in Q2 2015.
  • 357 funds tracked by Wall St. Rank held Bausch Health as of Q2 2021.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q2 2021, filed 16 Aug 2021.